Connect Biopharma Limite...

NASDAQ: CNTB · Real-Time Price · USD
1.94
-0.11 (-5.37%)
At close: Aug 18, 2025, 2:40 PM

Connect Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-23.22M 7.65M -28.8M -30.58M -56.68M -61.92M -56.65M -145.71M
Depreciation & Amortization
184K 476K 481.87K 506.13K 527.3K 502.72K 412.05K 221.39K
Stock-Based Compensation
4.89M 1.84M 3.26M 1.11K 1.43K 2.08K 2.9K 1.5K
Other Working Capital
-82.08K n/a 13.99M -1.27M 876.45K 2.47M -2.33M -724.62K
Other Non-Cash Items
126.13K -18.9M 8.67M 2.16M 10.74M 856.07K 691.6K 108.04M
Deferred Income Tax
n/a n/a 1.46M -1.46M -505.24K 2.12M n/a n/a
Change in Working Capital
2.44M 960K 11.2M -1.72M 1.43M 5.59M 4.19M -954.98K
Operating Cash Flow
-15.58M -7.38M -16.84M -31.09M -44.49M -52.85M -45.66M -39.08M
Capital Expenditures
-312.08K -436K -8.33K -285.67K -2.46M -1.74M -315.65K -7.07M
Cash Acquisitions
-2.94M n/a 2.96M -16.5K 6.12K 35.82K n/a n/a
Purchase of Investments
-15.41M n/a -1.64M -30.96M -30.94M -80.55M -11.23M -6.57M
Sales Maturities Of Investments
-39.7K n/a 39.69M 65.5M 27.39M 6.48M 11.29M 8.61M
Other Investing Acitivies
2.26M 13.15M -100.5K 16.5K -6.12K -35.82K 56.49 -702.95
Investing Cash Flow
-15.72M 3.03M 40.9M 34.25M -6M -75.81M -257.55K -5.03M
Debt Repayment
290K n/a -290K n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -5.46K -194.59
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-142K -46K -118.65K -61K -59.03K 35.18K -6.18M -17.3M
Financial Cash Flow
272.42K -46K -115.72K -130.28K -124.69K 35.18K 979.46K 203.66M
Net Cash Flow
-31.94M -3.93M -81.61M 2.02M -62.57M -126.09M -45.59M 159.55M
Free Cash Flow
-15.89M -8.41M -16.85M -31.37M -46.94M -54.59M -45.97M -46.15M